Welcome to CDC stacks |
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Interferon-gamma release assays (IGRAs) - blood tests for TB infection
  • Published Date:
    November, 2011
  • Language:
    English
Filetype[PDF-179.62 KB]


Details:
  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like:
  1. Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection -- United States, 2010
    Personal Author:
    Castro, Kenneth G.; Goldberg, Stefan; Jereb, John A.; LoBue, Philip; Mazurek, Gerald H.; Vernon, Andrew;
    Corporate Authors:
    National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.), Division of Tuberculosis Elimination.. Centers for Disease Control and Prevention (U.S.). HIV Medicine Association. Infectious Diseases Society of America. National Institutes of Health (U.S.).
    Published Date:
    June 25, 2010
    Series:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 59, no. RR-5
    Description:
    What are they? -- How do they work? -- What are the advantages of IGRAs? -- What are the disadvantages and limitations of IGRAs? -- What are the steps in administering an IGRA test? -- How do you interpret IGRA test results? -- Recommendations on whe...
    Status:
    current
    File Type:
    Filetype[PDF - 501.08 KB]
  2. Is It Time to Replace the Tuberculin Skin Test With a Blood Test?
    Personal Author:
    LoBue, Philip A.; Castro, Kenneth G.;
    Published Date:
    Jul 18 2012
    Source:
    JAMA. 308(3):241-242.
    Description:
    What are they? -- How do they work? -- What are the advantages of IGRAs? -- What are the disadvantages and limitations of IGRAs? -- What are the steps in administering an IGRA test? -- How do you interpret IGRA test results? -- Recommendations on whe...
    File Type:
    Filetype[PDF - 81.07 KB]
  3. Clinical Application of Interferon-γ Release Assays for the Prevention of Tuberculosis in Countries with Low Incidence
    Personal Author:
    Lange, Christoph; Mandalakas, Anna M.; Kalsdorf, Barbara; Denkinger, Claudia M.; Sester, Martina;
    Published Date:
    Jan 04 2016
    Source:
    Pathog Immun. 1(2):308-329
    Description:
    What are they? -- How do they work? -- What are the advantages of IGRAs? -- What are the disadvantages and limitations of IGRAs? -- What are the steps in administering an IGRA test? -- How do you interpret IGRA test results? -- Recommendations on whe...
    File Type:
    Filetype[PDF - 368.19 KB]
  4. Characteristics Associated with Negative Interferon-γ Release Assay Results in Culture-Confirmed Tuberculosis Patients, Texas, USA, 2013–2015
    Personal Author:
    Nguyen, Duc T.; Teeter, Larry D.; Graves, Julie; Graviss, Edward A.;
    Published Date:
    Mar 2018
    Source:
    Emerg Infect Dis. 24(3):534-540.
    Description:
    What are they? -- How do they work? -- What are the advantages of IGRAs? -- What are the disadvantages and limitations of IGRAs? -- What are the steps in administering an IGRA test? -- How do you interpret IGRA test results? -- Recommendations on whe...
    File Type:
    Filetype[PDF - 2.00 MB]
  5. Unusual Interferon Gamma Measurements with QuantiFERON-TB Gold and QuantiFERON-TB Gold In-Tube Tests
    Personal Author:
    Powell, Richard D.; Whitworth, William C.; Bernardo, John; Moonan, Patrick K.; Mazurek, Gerald H.;
    Published Date:
    Jun 08 2011
    Source:
    PLoS One. 2011; 6(6).
    Description:
    What are they? -- How do they work? -- What are the advantages of IGRAs? -- What are the disadvantages and limitations of IGRAs? -- What are the steps in administering an IGRA test? -- How do you interpret IGRA test results? -- Recommendations on whe...
    File Type:
    Filetype[PDF - 252.88 KB]